Literature DB >> 7568237

Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells.

E Papakonstantinou1, G Karakiulakis, M Roth, L H Block.   

Abstract

Total glycans from the cell layer and the culture medium of human vascular smooth muscle cells (VSMC) that had been cultivated in the presence of platelet-derived growth factor (PDGF) were isolated and purified by gel filtration after Pronase and DNase digestion and alkaliborohydride treatment. Measurements of the content of neutral hexoses and uronic acids revealed that PDGF stimulates total glycan synthesis by proliferating VSMC in a linear fashion from 24 h to 72 h of incubation. In contrast, total glycan synthesis by human fibroblasts, epithelial cells, or endothelial cells was not affected by PDGF, indicating cell-type specificity. Chemical, biochemical, and enzymological characterization of the total glycans synthesized by VSMC showed that PDGF stimulates the secretion of a 340-kDa glycan molecule in a time-dependent manner from 24 h to 72 h. This molecule is highly acidic, shares a common structure with hyaluronic acid, and exhibits a potent antiproliferative activity on VSMC. These results suggest that VSMC in response to PDGF are capable of controlling their own growth and migration by the synthesis of a specific form of hyaluronic acid with antiproliferative potency, which may be involved in the regulation of the local inflammatory responses associated with atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568237      PMCID: PMC40906          DOI: 10.1073/pnas.92.21.9881

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  The biology of platelet-derived growth factor.

Authors:  R Ross; E W Raines; D F Bowen-Pope
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

2.  Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. I. Evidence for reversible binding and inactivation of the platelet-derived growth factor by heparin.

Authors:  G Fager; G Camejo; G Bondjers
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

3.  Composition of proteoglycans from human atherosclerotic lesions.

Authors:  E R Dalferes; B Radhakrishnamurthy; H A Ruiz; G S Berenson
Journal:  Exp Mol Pathol       Date:  1987-12       Impact factor: 3.362

4.  Two classes of PDGF receptor recognize different isoforms of PDGF.

Authors:  C E Hart; J W Forstrom; J D Kelly; R A Seifert; R A Smith; R Ross; M J Murray; D F Bowen-Pope
Journal:  Science       Date:  1988-06-10       Impact factor: 47.728

5.  Rapid analysis of amino acids using pre-column derivatization.

Authors:  B A Bidlingmeyer; S A Cohen; T L Tarvin
Journal:  J Chromatogr       Date:  1984-12-07

6.  Expressions of the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase genes are stimulated by recombinant platelet-derived growth factor isomers.

Authors:  M Roth; L R Emmons; A Perruchoud; L H Block
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

7.  Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds.

Authors:  G F Pierce; J Vande Berg; R Rudolph; J Tarpley; T A Mustoe
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

8.  Localization of PDGF-B protein in macrophages in all phases of atherogenesis.

Authors:  R Ross; J Masuda; E W Raines; A M Gown; S Katsuda; M Sasahara; L T Malden; H Masuko; H Sato
Journal:  Science       Date:  1990-05-25       Impact factor: 47.728

9.  A procedure for the quantitative isolation of brain gangliosides.

Authors:  L Svennerholm; P Fredman
Journal:  Biochim Biophys Acta       Date:  1980-01-18

10.  Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions.

Authors:  K Rubin; A Tingström; G K Hansson; E Larsson; L Rönnstrand; L Klareskog; L Claesson-Welsh; C H Heldin; B Fellström; L Terracio
Journal:  Lancet       Date:  1988-06-18       Impact factor: 79.321

View more
  17 in total

1.  Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta.

Authors:  S P Evanko; E W Raines; R Ross; L I Gold; T N Wight
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

2.  Infrared irradiation alters the expression of matrix metalloproteinases and glycosaminoglycans in the cornea and crystalline lens.

Authors:  Panagiotis Dadoukis; Ioannis Klagas; Anastasia Komnenou; George Karakiulakis; Athanasios Karoutis; Vassilios Karampatakis; Eleni Papakonstantinou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-28       Impact factor: 3.117

3.  The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation.

Authors:  C A Cuff; D Kothapalli; I Azonobi; S Chun; Y Zhang; R Belkin; C Yeh; A Secreto; R K Assoian; D J Rader; E Puré
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

4.  Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus.

Authors:  Utako Yokoyama; Susumu Minamisawa; Hong Quan; Shibnath Ghatak; Toru Akaike; Eri Segi-Nishida; Shiho Iwasaki; Mari Iwamoto; Suniti Misra; Kouichi Tamura; Hideaki Hori; Shumpei Yokota; Bryan P Toole; Yukihiko Sugimoto; Yoshihiro Ishikawa
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

Review 5.  Hyaluronan as an immune regulator in human diseases.

Authors:  Dianhua Jiang; Jiurong Liang; Paul W Noble
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

6.  Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.

Authors:  C M McKee; M B Penno; M Cowman; M D Burdick; R M Strieter; C Bao; P W Noble
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

Review 7.  Hyaluronan-dependent pericellular matrix.

Authors:  Stephen P Evanko; Markku I Tammi; Raija H Tammi; Thomas N Wight
Journal:  Adv Drug Deliv Rev       Date:  2007-08-14       Impact factor: 15.470

8.  Enhanced flexor tendon healing through controlled delivery of PDGF-BB.

Authors:  Stavros Thomopoulos; Rosalina Das; Matthew J Silva; Shelly Sakiyama-Elbert; Frederick L Harwood; Emmanouil Zampiakis; H Mike Kim; David Amiel; Richard H Gelberman
Journal:  J Orthop Res       Date:  2009-09       Impact factor: 3.494

Review 9.  The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance.

Authors:  Eleni Papakonstantinou; George Karakiulakis
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

10.  High levels of hyaluronan in idiopathic pulmonary arterial hypertension.

Authors:  Metin Aytekin; Suzy A A Comhair; Carol de la Motte; Sudip K Bandyopadhyay; Carol F Farver; Vincent C Hascall; Serpil C Erzurum; Raed A Dweik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-05       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.